Navigation Links
Sugar-hungry yeast to boost biofuel production
Date:3/28/2010

Engineering yeast to transform sugars more efficiently into alcohols could be an economically and environmentally sound way to replace fossil fuels, say scientists presenting at the Society for General Microbiology's spring meeting in Edinburgh today.

Dr Christian Weber and Professor Eckhard Boles from Frankfurt University, Germany, have worked out how to modify yeast cells so that they successfully convert a wider range of sugars from plant waste such as wheat and rice straw into alcohol that can be used as biofuel.

Bioalcohols produced by microbial fermentations are an example of second generation biofuels that use raw materials not used in food production. Plant waste is available in large amounts and contains a mixture of complex sugars including hexoses and pentoses that can be fermented to alcohol. "As these feedstocks represent the biggest portion of processing costs, we need rapid and efficient conversion of all sugars present. At the moment there is a lack of microbes that will efficiently convert both hexoses and pentoses into ethanol," explained Dr Weber.

Bakers' yeast Saccharomyces cerevisiae is already used in the beverage industry to efficiently convert hexose sugars, such as glucose, into ethanol. By transferring genes from bacteria that naturally break down pentose, Dr Weber's team have engineered S. cerevisiae to successfully ferment pentose and hexose sugars. "As pentoses represent a substantial part of the feedstock, the engineered yeast gives a much higher yield of ethanol for the same amount of feedstock," he said.

To enhance their biofuel potential even more, the yeast is being further modified to produce another bioalcohol - butanol instead of ethanol. "Compared to ethanol, butanol shows superior properties as a potential biofuel." It has a lower vapour pressure, ignites at a higher temperature and is less corrosive. Butanol could replace fossil fuels up to 100% without modifying existing engines," said Professor Boles.

BUTALCO is a company started by Professor Boles together with chemist Dr Gunter Festel that is developing a special technology to modify the yeast for pentose utilization and butanol production. The company is currently finalising the technology to use both pentoses and hexoses for bioethanol manufacture. Eventually a whole process chain will be developed covering all the steps of bioalcohol production from engineering through to downstream processing.


'/>"/>

Contact: Laura Udakis
l.udakis@sgm.ac.uk
44-118-988-1843
Society for General Microbiology
Source:Eurekalert

Related biology news :

1. 2010 Yeast Genetics and Molecular Biology Meeting
2. Charles Drew cancer studies with yeast yield excellent results
3. Helpful yeast battles food-contaminating aflatoxin
4. Yeast missing sex genes undergo unexpected sexual reproduction
5. Jungle yeast
6. New study reveals the protein that makes phosphate chains in yeast
7. Rhythmic genomics -- the yeast metronome and the walk of life
8. Commercial yeasts upgraded with an enzyme for biofuel production
9. Scientists study full protein content of bakers yeast
10. Genetic differences between yeasts greater than those between humans and chimpanzees
11. Caltech engineers build mini drug-producing biofactories in yeast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... 2016 Beike Biotechnology, the Shenzhen ... a ceremony in late 2015 to mark their successful ... 2016. --> --> ... Personalized Cell Therapy" was hosted by the Shenzhen Cell ... subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today provided ... Uniden in the Northern District of Texas ... forward.  Inter Partes Re-examination ("IPR") ... Patent Office.  The IPR was initiated on only certain ...
(Date:2/3/2016)... , Feb. 3, 2016   ViaCyte, ... with the first pluripotent stem cell-derived islet replacement ... in clinical-stage development, today announced that ViaCyte and ... Companies of Johnson & Johnson, have agreed to ... into ViaCyte.  The agreement provides ViaCyte with an ...
(Date:2/3/2016)... 3, 2016 New Jersey Health Foundation (NJHF) ... million for researchers in New Jersey ... that demonstrates exciting potential.   James ... the New Jersey Health Foundation Research Grant Program ... educational institutions— Princeton University, Rutgers University, Rowan University ...
Breaking Biology Technology: